Researchers in Scotland have found that although women whose first pregnancies are complicated by postpartum hemorrhage (PPH) do not have reduced fertility, they do have an increased risk of PPH in later pregnancies. Notably, they also found that women who have cesarean sections at the time of PPH are less likely to conceive again. The study was published January 23 in BJOG: An International Journal of Obstetrics and Gynaecology.
Researchers in Scotland have found that although women whose first pregnancies are complicated by postpartum hemorrhage (PPH) do not have reduced fertility, they do have an increased risk of PPH in later pregnancies. Notably, they also found that women who have cesarean sections at the time of PPH are less likely to conceive again. The study was published January 23 in BJOG: An International Journal of Obstetrics and Gynaecology.
The researchers conducted a study on PPH at the Aberdeen Maternity Hospital in Scotland over a 20-year period (1986-2005), using information from the Aberdeen Maternity and Neonatal Databank. Using data from 34,334 first pregnancies, they found that 10% experienced PPH.
The paper identified increased maternal age, high body mass index, and smoking as risk factors for PPH.
For the study, the 34,334 women were monitored for a minimum of 5 years to identify second pregnancies. Women who had experienced PPH in their first pregnancies were then compared to women who had not.
Researchers found that there were no significant differences between those who experienced PPH and those who did not for the proportion of women who went on to conceive a second pregnancy, in the time interval between pregnancies, or in early/late pregnancy loss.
However, mode of delivery among women who had initially experienced PPH was a significant factor in the likelihood of a second pregnancy, according to the study. Of the women who initially had cesarean sections complicated by PPH, 41.5% did not go on to have second pregnancies, compared to 36.8% of women who had cesarean sections that were not complicated by PPH.
Read other articles in this issue of Special Delivery.
Mosie Baby Kit receives class 2 FDA clearance for intravaginal insemination
December 6th 2023Discover how Mosie Baby's at-home insemination kit, the first FDA-cleared of its kind, empowers individuals facing infertility challenges with an effective, easy-to-use solution for intravaginal insemination.
Read More
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
How plasma biomarkers illuminate brain health in women with HIV
December 4th 2023Discoveries from a comprehensive study reveal specific plasma biomarkers that may serve as indicators of neurological well-being in individuals living with HIV, shedding light on potential links to Alzheimer's disease and emphasizing the importance of early detection for improved outcomes.
Read More